Recruiting
Investigational
A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis
Investigational
- Substances:–
Countries:
Denmark
Denmark- Participants:18–64 years
Find therapies in clinical trials near you
- recruiting
- 3 962
- countries
- 28
- conditions
- 2 101
3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today
36 trials match your criteria
Recruiting
Primary progressive multiple sclerosis
RecruitingInvestigational
Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis
Investigational
- Disease:Primary progressive multiple sclerosis
- Substances:–
Countries:Denmark
Denmark- Participants:18–64 years
Recruiting
Arteriosclerosis
RecruitingInvestigational
Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
Investigational
- Disease:Arteriosclerosis
- Substances:–
Countries:Denmark
Denmark- Participants:18–64 years · 65+ years
Recruiting
Arteriosclerosis
RecruitingInvestigational
Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
Investigational
- Disease:Arteriosclerosis
- Substances:Maridebart Cafraglutide
Countries:Denmark
Denmark- Participants:18–64 years · 65+ years
- Substances:Maridebart Cafraglutide
Recruiting
Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk
RecruitingRegistered drug
Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk
Registered drug
- Substances:BaxdrostatDapagliflozin
Countries:Denmark
Denmark- Participants:18–64 years · 65+ years
- Substances:Baxdrostat
Recruiting
Acute myocardial infarction
RecruitingInvestigational
Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
Investigational
- Disease:Acute myocardial infarction
- Substances:Selatogrel
Countries:Denmark
Denmark- Participants:18–64 years · 65+ years
- Substances:Selatogrel
Recruiting
Type 2 diabetes mellitus
RecruitingRegistered drug
Randomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function
Registered drug
- Disease:Type 2 diabetes mellitus
- Substances:Azd5004Dapagliflozin
Countries:Denmark
Denmark- Participants:18–64 years · 65+ years
- Substances:Azd5004
Recruiting
Cholangitis sclerosing
RecruitingInvestigational
A Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety
Investigational
- Disease:Cholangitis sclerosing
- Substances:Elafibranor
Countries:Denmark
Denmark- Participants:18–64 years · 65+ years
- Substances:Elafibranor
Recruiting
Colitis ulcerative
RecruitingInvestigational
A study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis
Investigational
- Disease:Colitis ulcerative
- Substances:MirikizumabMorf-057
Countries:Denmark
Denmark- Participants:18–64 years · 65+ years
- Substances:Mirikizumab
Recruiting
Acute myocardial infarction
RecruitingRegistered drug
A study evaluating the effect of methylprednisolone compared to sodium chloride in patients with a heart attack
Registered drug
- Disease:Acute myocardial infarction
- Substances:MethylprednisoloneSodium Chloride
Countries:Denmark
Denmark- Participants:18–64 years · 65+ years
- Substances:Methylprednisolone
Recruiting
Clostridium difficile infection
RecruitingInvestigational
A study to evaluate the effectiveness of AZD5148 in preventing the recurrence of Clostridioides difficile infection in adults.
Investigational
- Disease:Clostridium difficile infection
- Substances:AZD5148
Countries:Denmark
Denmark- Participants:18–64 years · 65+ years
- Substances:AZD5148
Recruiting
Acute kidney injury
RecruitingInvestigational
A study testing how well AZD4144 works and how safe it is for adults with acute kidney injury caused by sepsis
Investigational
- Disease:Acute kidney injury
- Substances:–
Countries:Denmark
Denmark- Participants:18–64 years · 65+ years